Cargando…
Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer
Cancer is a very heterogeneous disease, and biological variability adds a further level of complexity, thus limiting the ability to identify new genes involved in cancer development. Oncogenes whose expression levels control cell aggressiveness are very useful for developing cellular models that per...
Autores principales: | Maurizio, Elisa, Wiśniewski, Jacek R., Ciani, Yari, Amato, Angela, Arnoldo, Laura, Penzo, Carlotta, Pegoraro, Silvia, Giancotti, Vincenzo, Zambelli, Alberto, Piazza, Silvano, Manfioletti, Guidalberto, Sgarra, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Biochemistry and Molecular Biology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762532/ https://www.ncbi.nlm.nih.gov/pubmed/26527623 http://dx.doi.org/10.1074/mcp.M115.050401 |
Ejemplares similares
-
A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness
por: Pegoraro, Silvia, et al.
Publicado: (2015) -
HMGA1 regulates the Plasminogen activation system in the secretome of breast cancer cells
por: Resmini, Giulia, et al.
Publicado: (2017) -
HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness
por: Pegoraro, Silvia, et al.
Publicado: (2013) -
HMGA1 Modulates Gene Transcription Sustaining a Tumor Signalling Pathway Acting on the Epigenetic Status of Triple-Negative Breast Cancer Cells
por: Penzo, Carlotta, et al.
Publicado: (2019) -
HMGA1 promotes breast cancer angiogenesis supporting the stability, nuclear localization and transcriptional activity of FOXM1
por: Zanin, Rossella, et al.
Publicado: (2019)